Charles Van der Henst

This paper describes a nanobody-based method for targeting diverse Acinetobacter baumannii isolates and related species, demonstrating its effectiveness in capturing bacteria from complex mixtures.

This study introduces a novel Core-Gene Consensus Delimitation (CGCD) method to define species in Acinetobacter baumannii, identifying 11 distinct groups supported by genomic and phylogenetic analyses.

This study sequenced A. baumannii ST19 genomes and found a loss of the T6SS locus, replaced by antibiotic resistance transposons, potentially enhancing horizontal gene transfer and population-level competitiveness.

This paper develops a scalable framework for precision phage therapy by combining genomic surveillance and phage typing to target carbapenem-resistant Acinetobacter baumannii.

This study shows that capsule production in Acinetobacter baumannii affects adhesion to surfaces and natural transformability, highlighting a trade-off in virulence and genetic adaptability.

The paper introduces Acinetobase, a database that compiles Acinetobacter strains and their associated phenotypic and genetic data to address the heterogeneity of A. baumannii.